Announce Date | 05/22/2025 |
EPS Normalized Actual | $0.33 (Beat by $0.01) |
EPS GAAP Actual | $0.33 (Beat by $0.01) |
Revenue Actual | $1.90581B |
Revenue Surprise | Beat by $1905.81M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $2.77936 |
EPS GAAP Estimate | $2.77936 |
Revenue Estimate | $2.008537609B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 0 | INF | 0 | 0 | 2 |
Dec 2026 | 98.56006 | 0.34 | 89.70394 | 107.41618 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.74 | -0.34416 | 1.90581B | 22.96% | 343.81M |
FQ4 2024 (Dec 2024) | 0.8 | -0.91584 | 2.08401B | 27.77% | -827.72M |
FQ3 2024 (Sep 2024) | 0 | -1.96379 | 1.89858B | 31.84% | -689.63M |
FQ2 2024 (Jun 2024) | 0.3 | -1.32321 | 1.79705B | 100% | -467.63M |
FQ3 2020 (Sep 2020) | 0.99 | 0.99 | 0.513278B | 100% | 513.28M |
FQ4 2020 (Dec 2020) | 0.99 | 0.99 | 0.513278B | 100% | 513.28M |
FQ3 2021 (Sep 2021) | 0.28 | 0.28 | 0.578618B | 11.29% | 578.62M |
FQ4 2021 (Dec 2021) | 0.28 | 0.28 | 0.578618B | 11.29% | 578.62M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
2.77936
Consensus Revenue Estimates
2.008537609B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 5.20727 | -- | 5.20727 | 5.20727 | 1 |
FQ2 2027 (Jun 2027) | 4.87558 | -- | 4.87558 | 4.87558 | 1 |
FQ1 2027 (Mar 2027) | 3.81266 | -- | 3.81266 | 3.81266 | 1 |
FQ4 2026 (Dec 2026) | 3.51039 | -- | 3.10068 | 3.87227 | 0 |
FQ3 2026 (Sep 2026) | 3.48116 | -- | 3.40329 | 3.56795 | 0 |
FQ2 2026 (Jun 2026) | 3.08483 | -- | 3.01582 | 3.16174 | 0 |
FQ1 2026 (Mar 2026) | 2.56892 | 32.27 | 2.26909 | 2.83375 | 0 |
FQ4 2025 (Dec 2025) | 2.04855 | 60.95 | 1.80945 | 2.25973 | 1 |
FQ3 2025 (Sep 2025) | 2.77936 | -- | 2.71719 | 2.84865 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 3.4B | -- | 3.4B | 3.4B | 2 |
FQ2 2027 (Jun 2027) | 3.4B | -- | 3.4B | 3.4B | 2 |
FQ1 2027 (Mar 2027) | 2.72B | -- | 2.72B | 2.72B | 1 |
FQ4 2026 (Dec 2026) | 3.16B | -- | 2.87B | 3.41B | 1 |
FQ3 2026 (Sep 2026) | 2.47B | -- | 2.43B | 2.52B | 1 |
FQ2 2026 (Jun 2026) | 2.18B | -- | 2.14B | 2.22B | 1 |
FQ1 2026 (Mar 2026) | 1.96B | 2.76 | 1.78B | 2.12B | 1 |
FQ4 2025 (Dec 2025) | 2.57B | 18.78 | 2.34B | 2.77B | 0 |
FQ3 2025 (Sep 2025) | 2.01B | 5.47 | 1.97B | 2.05B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 2.08416 | 1.74 | -0.34416 | -19.78% |
FQ4 2024 (Dec 2024) | 1.71584 | 0.8 | -0.91584 | -114.48% |
FQ3 2024 (Sep 2024) | 1.96379 | 0 | -1.96379 | -INF% |
FQ2 2024 (Jun 2024) | 1.62321 | 0.3 | -1.32321 | -441.07% |
FQ3 2020 (Sep 2020) | 0.99 | 0.99 | 100% | |
FQ4 2020 (Dec 2020) | 0.99 | 0.99 | 100% | |
FQ3 2021 (Sep 2021) | 0.28 | 0.28 | 100% | |
FQ4 2021 (Dec 2021) | 0.28 | 0.28 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $1.56B | $1.91B | $343.81M | 18.04% |
FQ4 2024 (Dec 2024) | $2.91B | $2.08B | $-827.72M | -39.72% |
FQ3 2024 (Sep 2024) | $2.59B | $1.9B | $-689.63M | -36.32% |
FQ2 2024 (Jun 2024) | $2.26B | $1.8B | $-467.63M | -26.02% |
FQ3 2020 (Sep 2020) | $0B | $0.51B | $513.28M | 100% |
FQ4 2020 (Dec 2020) | $0B | $0.51B | $513.28M | 100% |
FQ3 2021 (Sep 2021) | $0B | $0.58B | $578.62M | 100% |
FQ4 2021 (Dec 2021) | $0B | $0.58B | $578.62M | 100% |